aVR导联ST段抬高对阵发性室上性心动过速的鉴别价值

目的探讨aVR导联ST段抬高及其持续时间对阵发性室上性心动过速（PSVT）的鉴别价值。方法126例行射频消融治疗成功的PSVT患者，其中房室折返性心动过速（AVRT）65例，房室结折返性心动过速（AVNRT）61例。分析其aVR导联ST段抬高幅度及持续时间。结果65例AVRT中aVR导联ST抬高且持续时间≥0．08s有46例，61例AVNRT中有13例，诊断AVRT的敏感性、特异性及阳性预测值分别为70．8％，78．7％，78．0％；46例aVR导联ST段抬高的AVRT中左侧旁道占38例，诊断左侧旁道的敏感性、特异性及阳性预测值分别为79．2％，52．9％，82．6％。结论aVR导联ST段抬高及其持续时间有助于鉴别阵发性室上性心动过速，且其多发生于左侧旁道。     

aVR导联ST段抬高对阵发性室上性心动过速的鉴别价值

目的探讨aVR导联ST段抬高及其持续时间对阵发性室上性心动过速(PSVT)的鉴别价值。方法126例行射频消融治疗成功的PSVT患者,其中房室折返性心动过速(AVRT)65例,房室结折返性心动过速(AVNRT)61例。分析其aVR导联ST段抬高幅度及持续时间。结果65例AVRT中aVR导联ST抬高且持续时间≥0.08s有46例,61例AVNRT中有13例,诊断AVRT的敏感性、特异性及阳性预测值分别为70.8%,78.7%,78.0%;46例aVR导联ST段抬高的AVRT中左侧旁道占38例,诊断左侧旁道的敏感性、特异性及阳性预测值分别为79.2%,52.9%,82.6%。结论aVR导联ST段抬高及其持续时间有助于鉴别阵发性室上性心动过速,且其多发生于左侧旁道。     

aVR导联ST段抬高对急性心肌梗死预后的价值

目的探讨心电图aVR导联ST段抬高对急性前壁心肌梗死患者预后的价值。方法首次入院急性前壁心肌梗死患者57例，对其心电图和冠状动脉造影及临床资料进行对比分析。根据心电图aVR导联ST段变化分为抬高组、无偏移组。结果梗死相关血管为左主干病变的ST段抬高组、ST段无偏移组分别为5例（21．7％）、1例（2．9％），两组统计有显著性差异（p〈0．01）；病变范围为多支病变ST段抬高组、ST段无偏移组分别为10例（43．4％）、8例（23．5％），两组统计有显著性差异（p〈0．05）；发生心脏事件ST段抬高组、ST段无偏移组分别为8例（34.8％）、3例（8．8％），两组有显著性差异（p〈0．01）。结论aVR导联ST段抬高对预测急性前壁心肌梗死患者的预后有重要的价值，应高度重视。     

aVR导联与阵发性室上性心动过速相关性研究

目的研究aVR导联中ST段抬高对阵发性室上性心动过速(PSVT)的诊断价值。方法分析PSVT发作时在aVR导联中ST段抬高情况,同时结合心电生理检查结果对其进行对比分析。结果 259例PSVT者按折返部位不同分为两组:①A组:房室折返性心动过速者158例,占61.00%;②B组:房室结折返性心动过速者101例,占39.00%。A组中PSVT发作时aVR导联ST段抬高者59例,占37.34%;B组中PSVT发作时aVR导联ST段抬高者79例,占78.22%。B组显著高于A组。A组中有左侧旁道参与的PVST者有75例(A1组),其中PSVT发作时aVR导联ST段抬高者64例,占85.33%。结论 aVR导联ST段抬高对有旁道参与的PVST有诊断价值,特别是左侧旁道参与者有十分明显的鉴别诊断意义。     

aVR导联ST段抬高对非ST段抬高型急性心肌梗死的意义

目的：探讨aVR导联ST段抬高（ ST segment elevation ,STSE）对于非STSE型急性心肌梗死（ acute myocardial infarction , AMI ）的预测价值。方法回顾性分析425例非STSE 型AMI患者的心电图资料,并观察各导联ST段压低情况及是否存在T波倒置。对所测定数据进行整理和统计学处理。结果 aVR导联STSE多见于完全性右束支阻滞、左心室肥厚以及V1导联STSE的患者,在其他导联广泛ST段压低的患者中也较为多见;此类情况在T波倒置患者中较少见。本研究中,22例在住院时死亡,其中5例死于心源性休克。患者住院死亡率的不断升高和aVR导联STSE的等级不断上升相关。多重变量分析表明,aVR导联STSE已经成为预测住院死亡的独立重要变量。 aVR导联STSE大都与住院患者的心肌缺血时间以及发生心力衰竭相关,但是与血清肌酸激酶或肌酸激酶同工酶 MB 的水平高低没有相关性。结论如果aVR导联STSE和严重冠状动脉病变之间的联系,能够在大样本非STSE型AMI患者群体中得到进一步验证,那么aVR导联STSE就可以成为选择早期介入治疗患者的一个较为有用的指标。     

急性右心室梗死表现aVR导联ST段明显抬高

患者男,81岁。因气急胸闷加重1h于1987年12月9日入院,于1987年12月20日出现活动后胸闷、气急、伴随冷汗、恶心、呕吐,反复加重。既往有高血压病史多年,查体163/83mmHg,脉搏90次/min,不能平卧,颈静脉怒张,胸廓正常,右下肺可闻及哮鸣音和少许干湿罗音,伴双下肢浮肿。心电图示:窦性心律,右胸导联V_3R～V_5R呈Qr型,ST     

aVR导联ST段抬高对急性前壁心肌梗死的预后价值研究

目的探讨aVR导联ST段抬高对急性前壁心肌梗死患者的预后价值。方法根据心电图aVR导联ST段变化将84例急性前壁心肌梗死患者分为ST段抬高组（A组,44例）及ST段无抬高组（B组,40例）,对比分析两组患者的心电图和冠状动脉造影（CAG）及心血管事件发生率。结果 （1）梗死相关血管为左主干病变的A组9例（20.45%）与B组1例（2.50%）,两组统计有显著性差异（P〈0.05）;（2）梗死相关血管为三支病变的A组27例（61.36%）与B组10例（25.00%）,两组统计有显著性差异（P〈0.05）;（3）发生心血管事件的A组10例（22.73%）与B组3例（7.50%）,两组统计有显著性差异（P〈0.05）。结论 aVR导联ST段抬高对急性前壁心肌梗死患者预后有重要预测价值,应高度重视。     

aVR导联S T段抬高预测非S T段抬高型急性心肌梗死的临床价值

目的：探讨aVR导联ST段抬高对非ST段抬高型急性心肌梗死的预测价值。方法选取27例心电图改变为ST段压低≥0．1 mV伴aVR导联ST段抬高者作为观察组,另选50例ST段压低≥0．1 mV但不伴aVR导联ST段抬高者作为对照组,追踪观察2组非ST段抬高型急性心肌梗死的发生率。结果临床确诊为非 ST 段抬高型心肌梗死者观察组为7例（25．9％）,对照组为1例（2％）;2组比较差异有统计学意义（P＜0．05）。结论 aVR导联ST段抬高对非ST段抬高型急性心肌梗死具有一定的预测价值,临床应给予重视。     

aVL和aVR导联在室上速鉴别中的意义

目的对比研究a VL导联和a VR导联在鉴别室上性心动过速中的意义。方法选取我院2010年6月至2014年6月因心动过速就诊并经心脏电生理检查及射频消融证实为慢快型房室结折返性心动过速（SF-AVNRT,n=58）或顺向性房室折返性心动过速（AVRT,n=74）患者132例,与窦性心律相比,观察a VL导联切迹和a VR导联假性r波或粗顿的发生率。结果 AVNRT和AVRT中a VL导联出现切迹的发生率为53.4%和8.1%（p〈0.05）,差异有统计学意义,AVNRT和AVRT中a VR导联出现假性r波或粗顿的发生率为72.4%和6.8%（p〈0.05）,a VL切迹和a VR假r波或粗顿在AVNRT中的发生率53.4%和72.4%（p〈0.01）,差异有统计学意义。结论 a VL切迹和a VR导联假性r波均常见于AVNRT,有助于AVNRT的鉴别诊断,而a VR导联具有更高的敏感性。     

急性心肌梗死aVR导联ST段抬高的临床意义

目的 探讨体表心电图aVR导联ST段抬高对急性心肌梗死患者梗死相关血管(IRA)诊断及临床预后的意义.方法 收集2010年10月至2012年12月因急性心肌梗死入住我院的患者共240例,根据患者入院时心电图aVR导联ST段有无抬高,分为A组(AVR导联ST段抬高)80例和B组(aVR导联ST段无抬高)160例,对两组患者临床资料、冠状动脉造影结果及主要不良心血管事件进行对比.结果 ①两组患者性别、糖尿病病史、PCI病史等一般临床资料对比差异无统计学意义(P＞0.05).②两组冠状动脉造影结果比较:IRA为左主干(LM),A组9例,B组3例,两组比较差异有统计学意义(P＜0.01);IRA左主干和(或)三支血管(LM/3VD),A组46例,B组15例,两组比较差异有统计学意义(P＜0.01).③aVR导联ST抬高对IRA为左主干的敏感性及特异性分别为75％和69％,对IRA为左主干和(或)三支病变的敏感度及特异度分别为73％和81％.④住院期间主要不良心血管事件(MACE),A组36例,B组25例,两组比较差异有统计学意义(P＜0.01).⑤在住院期间,aVR导联ST段抬高(OR=10.03,95％CI=5.36～18.77,P＜0.01)是急性心肌梗死患者发生不良心血管事件的独立危险因素.结论 aVR导联ST段抬高提示急性心肌梗死患者梗死相关血管为左主干和(或)三支血管病变及住院期间不良心血管事件发生率增高.aVR导联ST段抬高对急性心肌梗死患者梗死相关血管判断及临床预后具有一定的临床指导意义.     

射频导管消融慢径路治疗程控刺激不能诱发且无明显跳跃的房室结折返性心动过速疗效分析

目的观察无A—H间期跳跃和不能诱发的房室结折返性心动过速（AVNRT）慢径路消融特点和远期疗效。方法经电生理检查证实无旁道参与的阵发性室上性心动过速患者100例,分成三组：能诱发AVNRT,有明显跳跃（A组,n=40）;不能诱发AVNRT,但有A—H间期〉50ms的明显跳跃（B组,1=40）;不能诱发AVNRT且没有A—H间期〉50ms的明显跳跃（C组．n=20）。比较术后各组电生理数值及消融远期疗效。结果与消融术前相比．术后各组患者的房室结顺传文氏周期均延长（P〈0．05）;消融术后房室结顺传有效不应期较术前缩短,差异有统计学意义（P〈0．05）;三组均出现缓慢交接区心律。术后随访12个月．各组复发率差异无统计学意义（P〉0．05）。结论无A—H间期跳跃且程控刺激不能诱发的AVNRT的慢径路消融是安全有效的。缓慢交接区心律是消融有效的标志。     

Differential Effect of Adenosine on Anterograde and Retrograde Fast Pathway Conduction in Patients with Atrioventricular Nodal Reentrant Tachycardia

Adenosine and Retrograde Fast Pathway Conduction . Introduction : Several studies have shown that the fast pathway is more responsive to adenosine than the slow pathway in patients with AV nodal reentrant tachycardia. Little information is available regarding the effect of adenosine on anterograde and retrograde fast pathway conduction.
Methods and Results : The effects of adenosine on anterograde and retrograde fast pathway conduction were evaluated in 116 patients (mean age 47 ± 16 years) with typical AV nodal reentrant tachycardia. Each patient received 12 mg of adenosine during ventricular pacing at a cycle length 20 msec longer than the fast pathway VA block cycle length and during sinus rhythm or atrial pacing at 20 msec longer than the fast pathway AV block cycle length. Anterograde block occurred in 98% of patients compared with retrograde fast pathway block in 62% of patients ( P < 0.001). Unresponsiveness of the retrograde fast pathway to adenosine was associated with a shorter AV block cycle length (374 ± 78 vs 333 ± 74 msec, P < 0.01), a shorter VA block cycle length (383 ± 121 vs 307 ± 49 msec, P < 0.001), and a shorter VA interval during tachycardia (53 ± 23 vs 41 ± 17 msec, P < 0.01).
Conclusion : Although anterograde fast pathway conduction is almost always blocked by 12 mg of adenosine, retrograde fast pathway conduction is not blocked by adenosine in 38% of patients with typical AV nodal reentrant tachycardia. This indicates that the anterograde and retrograde fast pathways may be anatomically and/or functionally distinct. Unresponsiveness of VA conduction to adenosine is not a reliable indicator of an accessory pathway.     

Retrograde Multiple and Multifiber Accessory Pathway Conduction in the Wolff-Parkinson-White Syndrome:

Retrograde Multiple Accessory Pathway Precipitating AF. Introduction : The determinants of susceptibility to atrial fibrillation (AF) and the existence of accessory pathway conduction have remained unidentified in the Wolff-Parkinson-White (WPW) syndrome. We tested the hypothesis that excitation inputs into the atrium over a retrograde multiple or multifiber accessory pathway during AV reentrant tachycardia (AVRT) could precipitate initiation of AF.
Methods and Results : Two hundred fifty consecutive patients with WPW syndrome underwent electrophysiologic study and radiofrequency catheter ablation. The patients were classified into two groups according to the study results: 29 with retrograde multiple or multifiber accessory pathway (MP) and 221 with retrograde single accessory pathway (SP). Compared with the SP patients, the MP patients showed a significantly higher incidence of clinical AF (MP vs SP: 19/29 vs 51/221, P < 0.01), induced AF (12/29 vs 32/221, P < 0.01), and initiated AF during ventricular pacing and AVRT (10/12 vs 17/32, P < 0.05). There were no differences between the two groups in incidence of clinical and induced AVRT (24/29 vs 200/221 and 25/29 vs 206/221, respectively), mean cycle length of induced AVRT, or electrophysiologic parameters of the accessory pathway. AF inducibility during AVRT or ventricular pacing was eliminated by partial ablation in 7 of 10 patients with MP. After total ablation, the incidence of induced AF was similar between the two groups (MP vs SP: 1/29 vs 11/221).
Conclusion : The existence of a retrograde multiple or multifiber accessory pathway in patients with WPW syndrome is associated with a higher incidence of clinical and induced AF. Successful ablation of the retrograde multiple or multifiber accessory pathway can eliminate the induction of both AVRT and AF.     

Case Report: Clinical AV Nodal Reentrant Tachycardia in a Patient with Left Sided Accessory Pathway and Immediate Occurrence of Antidromic AV Reentrant Tachycardia after Slow Pathway Ablation

The only inducible arrhythmia in a patient with exclusive antegrade conducting left anterolateral accessory pathway, consists of slow/fast atrioventricular nodal reentrant tachycardia. After radiofrequency catheter ablation of the slow pathway, true antidromic AV reentrant tachycardia was easily induced by atrial pacing. Following ablation of the accessory pathway no arrhythmia could be induced.     

隐匿性拖带时起搏后间期与慢径消融成功靶点的关系

评价应用隐匿性拖带方法对准确靶点消融的有效性及探讨常规慢径靶点部位与房室结折返性心动过速(AVNRT)折返环的关系。可反复诱发的持续性典型AVNRT的患者 34例 ,消融导管在后或中间隔标测到A/V≤ 0 .5处 ,然后诱发心动过速 ,在高位右房 (HRA)和冠状窦口 (CSO)超速起搏产生隐匿性拖带 ,并按常规方法进行慢径消融。比较隐匿性拖带时靶点部位起搏后间期与心动过速周长的差值 (PPI-TCL值 )在成功靶点与不成功靶点区别。结果 :HRA超速起搏发生隐匿性拖带时 ,His束记录部位A波均为逆向夺获。而CSO超速起搏拖带时 ,32例His束记录部位A波为顺向夺获 ,另 2例为逆向夺获。在这 32例中共记录 5 4个靶点 ,成功靶点的PPI-TCL值明显小于不成功靶点 (12 .4± 5 .8msvs 32 .1± 18.6ms,P <0 .0 1)。PPI-TCL值≤ 2 0ms对靶点成功消融的敏感性和特异性分别为 84%、81%。结论 :本研究提示常规慢径消融成功部位作为房室结外的后部延伸组织参与组成AVNRT折返环或距其非常近。在可持续发作和诱发的AVNRT患者中 ,CSO部位起搏拖带顺向心房夺获时 ,靶点部位测出的PPI-TCL值≤ 2 0ms,可作为一种新的慢径路电生理定位消融方法     

房室旁道和房室结双径引起的折返性心动过速初次发病年龄和因素分析

探讨房室旁道 (简称房道 )和房室结双径引起的折返性心动过速的初次发病年龄。 15 5例旁道和房室结双径引起的折返性心动过速中 ,房室折返性心动过速 (AVRT) 10 6例、房室结折返性心动过速 (AVNRT) 4 9例。根据年龄和心动过速病程推算初次发病年龄 ,然后比较AVRT和AVNRT、左和右侧旁道并AVRT、显性和隐匿性旁道并AVRT、男性和女性心动过速患者的初发年龄。结果 :AVRT和AVNRT的初发年龄分别为 2 9.9± 12 .85岁和 32 .33±11.84岁 ,组间比较无显著性差异。左、右侧旁道并AVRT、显性和隐匿性AP并AVRT、男性和女性心动过速患者初发年龄比较差异均无显著性 ,均是 30岁左右。结论 :30岁左右是AVRT和AVNRT初次发病的高发年龄段 ,其他年龄段呈散在发病     

Optimal Target Site for Slow AV Nodal Pathway Ablation

INTRODUCTION: Although a variety of ablation techniques have been developed in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT), there have been few reports discussing the location of the optimal target site. Based on our early experiences, we hypothesized that radiofrequency (RF) current applied around the upper margin of the coronary sinus ostium (UCSO) results in the most effective and safe treatment of AVNRT. METHODS AND RESULTS: To confirm our hypothesis, the efficacy of RF currents applied around the UCSO guided by local electrograms in 59 patients (group B: predetermined focal mapping approach) were compared with the outcomes in 60 other patients previously treated with the standard electrogram-guided mapping method starting around the lower margin of the coronary sinus ostium (group A). The precise location of ablation catheters at successful sites (S) was also evaluated. All the patients were successfully treated without complications. Significantly fewer RF pulses and lower energies were needed in group B patients (mean RF applications: 4.3 vs 1.4 applications, mean total energy delivered: 4,699 vs 2,236 J in groups A and B, respectively, P < 0.01). Detailed analyses of the anatomical locations of S using CS venography in group B patients who received only a single RF application (46 patients) revealed that the distance between His and S varied according to the length of Koch's triangle, while that between S and UCSO was relatively constant. In 85 % of these 46 patients, S was located within 5 mm above and below the level of the UCSO. CONCLUSION: RF applications around the UCSO guided by local electrograms yielded excellent outcomes in AVNRT patients with wide varieties in the size of Koch's triangle. The optimal target site was located within 5 mm above and below the level of UCSO along the tricuspid annulus.     

Successful Targeted Ablation of the Pathway Potential in the Noncoronary Cusp of the Aortic Valve in an Infant with Incessant Orthodromic Atrioventricular Reentrant Tachycardia

A 4-month-old infant presented with incessant SVT and severe failure to thrive. At EP study, orthodromic-reciprocating tachycardia using an anteroseptal accessory pathway was identified. Detailed mapping on the right atrial septum failed to disclose a distinctly early site of atrial activation or a near-field pathway potential. Mapping in the noncoronary cusp of the aortic valve identified a discrete pathway potential that was successfully targeted for ablation. At 12-month follow-up after the procedure, there had been no recurrence of tachycardia.
Conclusion: Myocardial fibers above the aortic valve cusps may constitute the atrioventricular bypass connection and can be identified and targeted for successful ablation even in infants.     

Radiofrequency Catheter Ablation of the Anterosuperior and Posteroinferior Atrial Approaches to the AV Node for Treatment of AV Nodal Reentrant Tachycardia

Catheter Ablation Techniques in AVNRT. Radiofrequency catheter ablation has been established as a first-line curative treatment modality in patients with symptomatic AV nodal reentrant tachycardia (AVNRT). The successful sites of stepwise catheter ablation approaches of the so-called fast and slow pathways strongly suggest that AVNRT involves the atrial approaches to the AV node. The typical fast pathway ablation sites are located anterosuperior toward the apex of the triangle of Koch, which also contains the compact AV node, whereas the usual slow pathway ablation sites are located posteroinferior toward the base of the triangle of Koch at a greater distance to the compact AV node and bundle of His. Accordingly, ablation studies with large patient cohorts have demonstrated that fast pathway ablation carries a higher risk of inadvertent complete AV block. Thus, the slow pathway is clearly the primary target site, and fast pathway ablation is rarely necessary. Different approaches for slow pathway ablation have been elaborated: anatomically oriented stepwise techniques, ablation guided by double potentials recorded within the area of the slow pathway insertion, and combined techniques. The modern concept of AVNRT suggests that this arrhythmia involves the highly complex three-dimensional nonuniform anisotropic AV junctional area. Accordingly, mapping and ablation studies demonstrated that the anterior approach is not identical with fast pathway ablation, and the posterior approach is not identical with slow pathway ablation. Therefore, it is essential for interventional electrophysiologists to familiarize themsdves with the anatomic and electrophysiologic details of this complex and variable specialized AV junctional region. In this review, the anatomic and pathophysiologic aspects of the AV junctional area as they relate to interventional therapy are summarized briefly, and the catheter techniques for ablation of the so-called fast and slow AV nodal pathways for the treatment of AVNRT are described.